Stock Spotlight Archives - Page 235 of 379

ThursdayJun 04, 2020 2:14 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New CEO

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human-optimization sciences company with an emphasis on ketamine and psychedelic medicine, recently named Dr. Roger McIntyre as chief executive officer. An article discussing the company reads, “In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. . . . ‘My overarching aim as chief executive officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments,’ McIntyre stated in a news release. ‘The clinical infrastructure, complementary asset…

ThursdayJun 04, 2020 1:19 pm

QualityStocksNewsBreaks – Why Kingman Minerals Ltd. (TSX.V: KGS) Is ‘One to Watch’

Canada-based Kingman Minerals (TSX.V: KGS) is engaged in the acquisition, exploration and development of gold and silver properties in North America. An article discussing the company further reads, “Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold-exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the Western United States and the world. Burgex’s…

ThursdayJun 04, 2020 12:09 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Innovative Stock for Ads Program Contributes to Significant Sales Rebound

SRAX (NASDAQ: SRAX) recently held its FY 2019 and Q1 2020 results conference call (http://ibn.fm/YOcxB). An article further discussing the company’s results reads, “SRAX’s fiscal 2019 revenues of $3.6 million showed a 3% year-to-year increase while Q1 2020 sales fell to $350,000 relative to the $592,000 recorded in 2019, the latter decline largely a result of customers opting to defer their media spend to the second quarter. While first-quarter revenues tend to mark the seasonal low for the company, SRAX was able to launch new initiatives, namely its pioneering Stock for Ads program and BIGtoken Lighting Insights platform, both of which…

ThursdayJun 04, 2020 12:00 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Ideally Positioned to Capitalize on Trump Administration’s Strategy to Revitalize Nuclear Fuel, Uranium Industries

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, is strategically positioned to capitalize on the Trump administration’s recently announced plan to revitalize the U.S. nuclear energy industry (http://ibn.fm/mvTrl). An article discussing the company reads, “Trump’s proposal to spend $150 million on a strategic U.S. uranium reserve will purchase uranium from domestic uranium producers that include Energy Fuels, the largest producer of uranium in the United States in recent years, and with assets that have accounted for over one-third of the nation’s natural uranium supply since 2006. With a licensed capacity of more than…

MondayJun 01, 2020 2:55 pm

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) Inks Licensing, Distribution Agreement with FILMHUB

Vertically integrated motion-picture production company The Movie Studio (OTC: MVES) announced in April that it signed a licensing and distribution agreement with FILMHUB, an online marketplace for film creators and streaming services (http://ibn.fm/LLdvn). An article discussing the company reads, “In addition, the Movie Studio will license its catalog to FILMHUB for distribution by way of its online film marketplace. . . . ‘We are excited to begin to offer hundreds of titles on our OTT platform in addition to licensing our titles to FILMHUB and its associated OTT partners,’ MVES studio president and CEO Gordon Scott Venters stated in a…

MondayJun 01, 2020 2:09 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Applies Unique Database to Improve Cancer Outcomes

Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is leveraging its proprietary database of more than 150,000 tumor genomic and drug response profiles to improve cancer outcomes. An article discussing the company reads, “With a mission to improve the standard of care for cancer patients, Helomics’ TruTumor(TM) platform harnesses the power of the patient’s own living tumor to address challenges oncologists often face when assessing patients and individualizing treatments. The clinically validated (in ovarian cancer) cell-based functional platform is in use today and profiles patient tumors, identifying key biomarkers and how the tumor responds to drugs and helps the oncologist…

MondayJun 01, 2020 1:57 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing Premium Medical Teleconferences

Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides subscribers with three premium medical teleconferencing visits through Bonum Health and prescription delivery through the company’s DelivMeds same day/mail-order pharmaceuticals service each month under the standard membership rate. . . . ‘With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold; Telemedicine removes the barrier…

FridayMay 29, 2020 1:28 pm

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Completes Management Transition Process with Appointment of CEO, President

Sigma Labs (NASDAQ: SGLB), a leading provider of in-process, quality-assurance software for the additive manufacturing industry, recently appointed experienced software industry executive Mark K. Ruport as CEO and president (http://ibn.fm/oNSOj). The move finalizes the company’s management transition process. An article further discussing the new appointment reads, “In his new assignment, Ruport will leverage his experience with public and private software companies to lead Sigma Labs through a period of significant growth and success. ‘The ability to have an immediate, tangible impact on Sigma Labs with the apparent adoption of its incredible technology in the marketplace is a unique and exciting…

FridayMay 29, 2020 1:19 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Rebrands Investor Intelligence Platform

SRAX (NASDAQ: SRAX) recently announced the rebranding of its investor intelligence platform from SRAX IR to Sequire. An article further discussing the platform reads, “The investor-relations platform, which enables companies to monitor their shareholders’ buying and selling behavior and carry out virtual investor meetings among other services, announced that it had gained 59 corporate subscribers as of the end of 2019 — a remarkable 64% increase relative to the quarter ending Sept 30, 2019. . . . ‘We are thrilled to announce the new brand, giving the platform its own identity separate from SRAX,’ SRAX CEO and founder Christopher Miglino…

FridayMay 29, 2020 1:10 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Helomics Subsidiary Holds Unique Cancerous Tumor Inventory

Predictive Oncology (NASDAQ: POAI) CEO Dr. Carl Schwartz recently referred to the company’s Helomics subsidiary as a “major asset” during an exclusive NNW interview with Stuart Smith (http://ibn.fm/8knZX). An article discussing the interview reads, “During the interview, Schwartz pointed out that Helomics’ collection of more than 150,000 cancer tumors is the largest inventory of its kind in the world and that the impressive collection ‘was amassed over the last two decades by physicians sending in cancerous tumors to be tested with the known therapies of the time. The results of these tests were in turn sent back to the referring…

Site Search

Company Search

Category: Stock Spotlight